A former official of the FDA's generic drugs division has been charged with allegedly accepting a free trip to Hong Kong and furniture as bribes from a New York state drug manufacturer.

Charles Y. Chang, a former branch chief in the Food and Drug Adminstration's Division of Generic Drugs, was charged Tuesday in U.S. District Court with two counts of interstate travel in aid of racketeering. Each charge carries a maximum penalty of five years in prison and a $250,000 fine upon conviction.Chang is accused of taking bribes from American Therapeutics Inc., a generic drug manufacturer, said U.S. Attorney Breckinridge L. Willcox. The Bohemia, N.Y., drug manufacturer has not been charged.

Chang is the third person and the second FDA chemist to be charged in the wide-ranging investigation of alleged bribery in the generic drugs division.